Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5 instead of Revision: v3.5.4. This reflects a minor site revision rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:15.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a newer version of the page content. The change does not affect the study details displayed.
    Difference
    0.0%
    Check dated 2026-05-14T23:26:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated to v3.5.3, replacing the previous v3.5.2. This represents a minor documentation/versioning update and does not change study details or eligibility content.
    Difference
    0.0%
    Check dated 2026-04-30T17:27:24.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2; the v3.5.0 label was removed. This is a routine site maintenance update and does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-16T10:22:20.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page version was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:17:07.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:32.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.